Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:55 AM
Ignite Modification Date:
2025-12-25 @ 4:55 AM
NCT ID:
NCT00644618
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven
* locally advanced pancreatic adenocarcinoma stage
* No systemic metastases
* Age between 18-75
* Karnofsky-Performance Status equal to, or greater than 70 %
* At least a 2-dimensionally measurable tumor lesion
* Adequate renal and liver function
* Written consent statement
* Patients' compliance and geographical proximity
* Life expectancy equal to or greater than 3 months
Exclusion Criteria:
* Serious psychological disease
* Pregnancy and inadequate or not secure contraception or breastfeeding women
* Other previous malignant disease in the past two years
* Serious systemic concomitant diseases, excluding participation in a trial
* Other experimental treatment during or within 6 weeks prior to this trial (including chemotherapeutic medicine or immune-therapies)
* Every other condition or therapy assessed by the physician as an eventual risk for the patient or restricting the aims of the trial
* Distant metastasis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00644618
Study Brief:
Protocol Section:
NCT00644618